News Conference News LINC 2023 FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA L.A. McKeown June 08, 2023
News Conference News LINC 2020 Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment L.A. McKeown January 31, 2020
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Daily News Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies L.A. McKeown January 23, 2019
News Daily News RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease L.A. McKeown May 08, 2018
News Daily News REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months L.A. McKeown February 11, 2018
News Conference News ISET 2017 Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial Caitlin E. Cox February 15, 2017
News Conference News ISET 2017 Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study Caitlin E. Cox February 10, 2017
News Conference News EuroPCR 2015 Studies Provide Encouraging Results for DCB in Long SFA Lesions Caitlin E. Cox May 22, 2015
News Daily News Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS Jason Kahn February 20, 2014
News Daily News First-Generation Bioresorbable Stent Performs Well in SFA Lesions Jason Kahn February 20, 2014
News Daily News Drug-Eluting Balloon Continues Strong Showing in SFA Lesions Jason Kahn March 22, 2012
News Daily News Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease Jason Kahn September 15, 2011